Liberty Health Enters Exclusive Partnership With AdaViv

Liberty Health Sciences (CSE:LHS) announced a partnership with AdaViv to improve the production of its 360 Innovation Campus in Florida.

As quoted in the press release:

AdaViv will integrate its adaptive Computer Vision software and Machine Learning platform into Liberty’s 360 Innovation Campus and, together, will look to push the state-of-the-art in greenhouse technology and precision growing to new levels of productivity and efficiency.

AdaViv’s technology enables 24/7 plant-level inspection as well as AI computer vision to uncover hidden plant biometrics that translates data into actionable insights for growers like Liberty. Founded by an interdisciplinary team of MIT researchers and alumni, AdaViv is led by Dr. Ian Seiferling (CEO), Julian Ortiz (COO, MBA MIT Sloan ’19) and Dr. Thomas Matarazzo (CTO). AdaViv emerged from MIT Delta V, the capstone entrepreneurship accelerator at MIT, and the MIT DesignX accelerator. In 2018, AdaViv was selected as one of the first grantees of Microsoft AI for Earth.

“This partnership demonstrates Liberty’s commitment for being a cutting-edge company that consistently looks for new ways to advance common practices through data and technology,” said George Scorsis, CEO of Liberty Health Sciences. “Working together, we hope to refine AdaViv’s game changing data capture and growth analytics technology to help us achieve the highest quality, consistency and yield for our crops, as well as monitor our plants in ways that our eyes never could. AdaViv will provide us with actionable knowledge, backed by real-time data. This will not only increase our output, but it will also boost our quality in a data driven format.”

Click here to read the full press release.

Source: www.newswire.ca